nodes	percent_of_prediction	percent_of_DWPC	metapath
Alizapride—DRD2—obesity	0.906	1	CbGaD
Alizapride—Remoxipride—DRD4—obesity	0.00227	0.237	CrCbGaD
Alizapride—Sulpiride—BCHE—obesity	0.00146	0.153	CrCbGaD
Alizapride—Remoxipride—DRD2—obesity	0.00135	0.142	CrCbGaD
Alizapride—Amisulpride—DRD2—obesity	0.0013	0.136	CrCbGaD
Alizapride—Sulpiride—DRD2—obesity	0.00114	0.119	CrCbGaD
Alizapride—Remoxipride—HTR2A—obesity	0.00105	0.109	CrCbGaD
Alizapride—Amisulpride—HTR2A—obesity	0.001	0.105	CrCbGaD
Alizapride—DRD2—GPCR ligand binding—CRH—obesity	0.000134	0.0016	CbGpPWpGaD
Alizapride—DRD2—Circadian rythm related genes—LEP—obesity	0.000133	0.00158	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PYY—obesity	0.000131	0.00156	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—APLN—obesity	0.000131	0.00156	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—HCRT—obesity	0.00013	0.00155	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—NPY5R—obesity	0.00013	0.00155	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PMCH—obesity	0.00013	0.00155	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—NMU—obesity	0.00013	0.00155	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—obesity	0.000128	0.00153	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—MKS1—obesity	0.000128	0.00152	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—KIF7—obesity	0.000128	0.00152	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—NPS—obesity	0.000127	0.00151	CbGpPWpGaD
Alizapride—DRD2—G alpha (i) signalling events—C3—obesity	0.000126	0.0015	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—NPY1R—obesity	0.000125	0.00149	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—MC4R—obesity	0.000125	0.00149	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—NPY2R—obesity	0.000125	0.00149	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—MC3R—obesity	0.000125	0.00149	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—HTR2C—obesity	0.000125	0.00148	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—DRD1—obesity	0.000125	0.00148	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PPY—obesity	0.000123	0.00146	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—ADRB1—obesity	0.000121	0.00144	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GIP—obesity	0.00012	0.00143	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PRKCH—obesity	0.00012	0.00143	CbGpPWpGaD
Alizapride—DRD2—G alpha (i) signalling events—AGT—obesity	0.00012	0.00143	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—HCRT—obesity	0.000118	0.00141	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—NPY5R—obesity	0.000118	0.00141	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—NMU—obesity	0.000118	0.00141	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PMCH—obesity	0.000118	0.00141	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—GHRL—obesity	0.000118	0.00141	CbGpPWpGaD
Alizapride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—obesity	0.000117	0.00139	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—DRD4—obesity	0.000117	0.00139	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PRLH—obesity	0.000117	0.00139	CbGpPWpGaD
Alizapride—DRD2—Circadian rythm related genes—PPARG—obesity	0.000116	0.00138	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—obesity	0.000114	0.00136	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—NPY1R—obesity	0.000113	0.00135	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—NPY2R—obesity	0.000113	0.00135	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—MC4R—obesity	0.000113	0.00135	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—MC3R—obesity	0.000113	0.00135	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CNR1—obesity	0.000112	0.00133	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PPY—obesity	0.000111	0.00133	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PRKCH—obesity	0.000109	0.0013	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GIP—obesity	0.000109	0.0013	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—GCG—obesity	0.000108	0.00129	CbGpPWpGaD
Alizapride—DRD2—Circadian rythm related genes—SERPINE1—obesity	0.000104	0.00124	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—ADRB3—obesity	0.000102	0.00122	CbGpPWpGaD
Alizapride—DRD2—G alpha (i) signalling events—POMC—obesity	0.000101	0.0012	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—obesity	0.0001	0.00119	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—obesity	0.0001	0.00119	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GAL—obesity	9.99e-05	0.00119	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—C5AR1—obesity	9.88e-05	0.00118	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—ADRB2—obesity	9.77e-05	0.00116	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NMB—obesity	9.67e-05	0.00115	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GHRH—obesity	9.67e-05	0.00115	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—obesity	9.52e-05	0.00113	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—GNB3—obesity	9.31e-05	0.00111	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—ADRB3—obesity	9.29e-05	0.00111	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—FFAR4—obesity	9.23e-05	0.0011	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GAL—obesity	9.07e-05	0.00108	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—GNAS—obesity	9.06e-05	0.00108	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CCK—obesity	9.03e-05	0.00108	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—C5AR1—obesity	8.97e-05	0.00107	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GHSR—obesity	8.84e-05	0.00105	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—MCHR1—obesity	8.84e-05	0.00105	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—BRS3—obesity	8.84e-05	0.00105	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GLP1R—obesity	8.8e-05	0.00105	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—F2—obesity	8.8e-05	0.00105	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CCL5—obesity	8.67e-05	0.00103	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CCKAR—obesity	8.66e-05	0.00103	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—HRH3—obesity	8.66e-05	0.00103	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SH2B1—obesity	8.22e-05	0.000979	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PRLHR—obesity	8.22e-05	0.000979	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GH1—obesity	8.22e-05	0.000979	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCK—obesity	8.2e-05	0.000977	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	8.01e-05	0.000954	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GLP1R—obesity	7.99e-05	0.000952	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—HRH3—obesity	7.86e-05	0.000937	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCKAR—obesity	7.86e-05	0.000937	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—NPY—obesity	7.85e-05	0.000934	CbGpPWpGaD
Alizapride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	7.84e-05	0.000934	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—IAPP—obesity	7.8e-05	0.000929	CbGpPWpGaD
Alizapride—DRD2—Circadian rythm related genes—MAPK8—obesity	7.77e-05	0.000925	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—APLN—obesity	7.73e-05	0.000921	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PYY—obesity	7.73e-05	0.000921	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—HTR2A—obesity	7.64e-05	0.00091	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—C3—obesity	7.63e-05	0.000909	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PRKAR2B—obesity	7.57e-05	0.000902	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CRH—obesity	7.57e-05	0.000902	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—HTR1B—obesity	7.57e-05	0.000902	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PNLIP—obesity	7.33e-05	0.000873	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—AGT—obesity	7.25e-05	0.000863	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—NPS—obesity	7.18e-05	0.000855	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SDC3—obesity	7.15e-05	0.000852	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—NPY—obesity	7.13e-05	0.000849	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—IAPP—obesity	7.08e-05	0.000843	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—DRD1—obesity	7.04e-05	0.000838	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—HTR2C—obesity	7.04e-05	0.000838	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—HCRT—obesity	6.99e-05	0.000833	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PMCH—obesity	6.99e-05	0.000833	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NMU—obesity	6.99e-05	0.000833	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NPY5R—obesity	6.99e-05	0.000833	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—HTR1B—obesity	6.87e-05	0.000819	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CRH—obesity	6.87e-05	0.000819	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—ADRB1—obesity	6.82e-05	0.000812	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NPY2R—obesity	6.7e-05	0.000798	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—MC3R—obesity	6.7e-05	0.000798	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—MC4R—obesity	6.7e-05	0.000798	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NPY1R—obesity	6.7e-05	0.000798	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—F2—obesity	6.7e-05	0.000798	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GHRL—obesity	6.67e-05	0.000795	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—DRD4—obesity	6.62e-05	0.000788	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PPY—obesity	6.57e-05	0.000783	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—NPS—obesity	6.52e-05	0.000776	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GIP—obesity	6.45e-05	0.000768	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PRKCH—obesity	6.45e-05	0.000768	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—HDAC8—obesity	6.45e-05	0.000768	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—DRD1—obesity	6.39e-05	0.000761	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—HTR2C—obesity	6.39e-05	0.000761	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CNR1—obesity	6.32e-05	0.000752	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—ADRB1—obesity	6.19e-05	0.000737	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—LEPR—obesity	6.13e-05	0.00073	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GCG—obesity	6.1e-05	0.000727	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—POMC—obesity	6.1e-05	0.000727	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GHRL—obesity	6.06e-05	0.000722	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—DRD4—obesity	6.01e-05	0.000716	CbGpPWpGaD
Alizapride—DRD2—GPCR ligand binding—CCL2—obesity	5.97e-05	0.000711	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CNR1—obesity	5.74e-05	0.000683	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GCG—obesity	5.54e-05	0.00066	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—ADRB2—obesity	5.52e-05	0.000658	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—ADRB3—obesity	5.49e-05	0.000653	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GAL—obesity	5.36e-05	0.000638	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—C5AR1—obesity	5.3e-05	0.000631	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GNB3—obesity	5.26e-05	0.000626	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—GNAS—obesity	5.12e-05	0.00061	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—ADRB2—obesity	5.01e-05	0.000597	CbGpPWpGaD
Alizapride—DRD2—Circadian rythm related genes—IL6—obesity	4.96e-05	0.000591	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—CCL5—obesity	4.9e-05	0.000583	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PRKG1—obesity	4.85e-05	0.000577	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCK—obesity	4.85e-05	0.000577	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GNB3—obesity	4.78e-05	0.000569	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—RBP4—obesity	4.72e-05	0.000562	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GLP1R—obesity	4.72e-05	0.000562	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—GNAS—obesity	4.65e-05	0.000554	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCKAR—obesity	4.65e-05	0.000553	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—HRH3—obesity	4.65e-05	0.000553	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PRKAR2B—obesity	4.47e-05	0.000533	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCL5—obesity	4.45e-05	0.00053	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PRKCD—obesity	4.41e-05	0.000525	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NCF2—obesity	4.32e-05	0.000514	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—HTR2A—obesity	4.32e-05	0.000514	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—C3—obesity	4.31e-05	0.000513	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NPY—obesity	4.21e-05	0.000501	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—IAPP—obesity	4.18e-05	0.000498	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—APOC3—obesity	4.18e-05	0.000498	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—AGT—obesity	4.1e-05	0.000488	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CRH—obesity	4.06e-05	0.000484	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—HTR1B—obesity	4.06e-05	0.000484	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SDC1—obesity	4.02e-05	0.000478	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PRKCD—obesity	4.01e-05	0.000477	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—AKR1C3—obesity	3.95e-05	0.00047	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—HTR2A—obesity	3.92e-05	0.000467	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—C3—obesity	3.91e-05	0.000466	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NPS—obesity	3.85e-05	0.000458	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—F2—obesity	3.78e-05	0.000451	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PRKCB—obesity	3.78e-05	0.000451	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—HTR2C—obesity	3.78e-05	0.00045	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—DRD1—obesity	3.78e-05	0.00045	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—AGT—obesity	3.72e-05	0.000443	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NTRK2—obesity	3.67e-05	0.000437	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—ADRB1—obesity	3.66e-05	0.000435	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PIK3CG—obesity	3.62e-05	0.000431	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PARP1—obesity	3.58e-05	0.000426	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GHRL—obesity	3.58e-05	0.000426	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—DRD4—obesity	3.55e-05	0.000423	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—POMC—obesity	3.45e-05	0.000411	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—F2—obesity	3.44e-05	0.000409	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PRKCB—obesity	3.44e-05	0.000409	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CNR1—obesity	3.39e-05	0.000404	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—TCF7L2—obesity	3.33e-05	0.000397	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—AKT2—obesity	3.31e-05	0.000395	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PIK3CG—obesity	3.29e-05	0.000392	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GCG—obesity	3.27e-05	0.00039	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PTPN1—obesity	3.27e-05	0.00039	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PIK3CD—obesity	3.18e-05	0.000379	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—POMC—obesity	3.13e-05	0.000373	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PRL—obesity	3.12e-05	0.000372	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—STK11—obesity	3.08e-05	0.000367	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—CCL2—obesity	3.06e-05	0.000365	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PLG—obesity	3.04e-05	0.000362	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—RHOA—obesity	3.04e-05	0.000362	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—AKT2—obesity	3.01e-05	0.000358	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PIK3R1—obesity	3.01e-05	0.000358	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—FOXO3—obesity	2.97e-05	0.000354	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—ADRB2—obesity	2.96e-05	0.000353	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SOCS1—obesity	2.92e-05	0.000347	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PIK3CD—obesity	2.89e-05	0.000344	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SOCS3—obesity	2.88e-05	0.000343	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GNB3—obesity	2.82e-05	0.000336	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—TYK2—obesity	2.78e-05	0.000331	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PIK3CB—obesity	2.78e-05	0.000331	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—IGF2—obesity	2.77e-05	0.00033	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—RHOA—obesity	2.76e-05	0.000329	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—GNAS—obesity	2.75e-05	0.000327	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PIK3R1—obesity	2.73e-05	0.000325	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—APOB—obesity	2.69e-05	0.00032	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCL5—obesity	2.63e-05	0.000313	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—LPL—obesity	2.57e-05	0.000306	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—FOXO1—obesity	2.55e-05	0.000304	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—RPS6KB1—obesity	2.55e-05	0.000303	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PIK3CB—obesity	2.52e-05	0.0003	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PRKCD—obesity	2.37e-05	0.000282	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—HTR2A—obesity	2.32e-05	0.000276	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—C3—obesity	2.31e-05	0.000275	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—IRS2—obesity	2.2e-05	0.000262	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—AGT—obesity	2.2e-05	0.000262	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—APOE—obesity	2.15e-05	0.000256	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—LEP—obesity	2.15e-05	0.000256	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CAV1—obesity	2.13e-05	0.000254	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—APOA1—obesity	2.13e-05	0.000253	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—ESR1—obesity	2.06e-05	0.000245	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—F2—obesity	2.03e-05	0.000242	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PRKCB—obesity	2.03e-05	0.000242	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—BAD—obesity	2.01e-05	0.000239	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PIK3CG—obesity	1.94e-05	0.000231	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—IRS1—obesity	1.92e-05	0.000229	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—POMC—obesity	1.85e-05	0.00022	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—INS—obesity	1.84e-05	0.000219	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—CCL2—obesity	1.81e-05	0.000216	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—IGF1—obesity	1.78e-05	0.000212	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—AKT2—obesity	1.78e-05	0.000212	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PIK3CD—obesity	1.71e-05	0.000203	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—PIK3CA—obesity	1.69e-05	0.000201	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—SERPINE1—obesity	1.69e-05	0.000201	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—TYK2—obesity	1.64e-05	0.000196	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—RHOA—obesity	1.63e-05	0.000194	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PIK3R1—obesity	1.61e-05	0.000192	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—NOS3—obesity	1.61e-05	0.000192	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—PIK3CA—obesity	1.54e-05	0.000183	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—MTOR—obesity	1.49e-05	0.000177	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PIK3CB—obesity	1.49e-05	0.000177	CbGpPWpGaD
Alizapride—DRD2—GPCR downstream signaling—AKT1—obesity	1.38e-05	0.000165	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—IL6—obesity	1.36e-05	0.000162	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—MMP9—obesity	1.29e-05	0.000154	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—MAPK8—obesity	1.26e-05	0.00015	CbGpPWpGaD
Alizapride—DRD2—Signaling by GPCR—AKT1—obesity	1.26e-05	0.000149	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—STAT3—obesity	1.15e-05	0.000137	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—MYC—obesity	1.07e-05	0.000127	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—TGFB1—obesity	1.07e-05	0.000127	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—PIK3CA—obesity	9.08e-06	0.000108	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—IL6—obesity	8.04e-06	9.57e-05	CbGpPWpGaD
Alizapride—DRD2—Signaling Pathways—AKT1—obesity	7.41e-06	8.83e-05	CbGpPWpGaD
